In some cancers, including head and neck cancer, ovarian cancer, breast cancer, and non-small-cell lung carcinoma (NSCLC), the Bcl-2 family of proteins correlates to cisplatin resistance and tumor recurrence [39]. Here, BCL2 is linked to cancer.